St. John's Wort
St. John's Wort is a strong CYP3A4 inducer and can markedly lower lurasidone exposure.
Recommendation: Do not combine St. John's Wort with lurasidone.
Prescription ·Strong evidence ·Reviewed May 2026
Lurasidone is an atypical antipsychotic used for schizophrenia and bipolar depression. It must be taken with a meal of at least 350 calories for adequate absorption and is highly dependent on CYP3A4 metabolism. It carries boxed warnings for increased mortality in elderly patients with dementia-related psychosis and suicidal thoughts and behaviors in younger patients when used for bipolar depression.
The bottom line
Evidence rating strong. Most-documented uses: treatment of schizophrenia in adults and adolescents, treatment of bipolar depression as monotherapy or adjunctive therapy, lower average metabolic burden than some antipsychotics, though monitoring remains necessary. 3 sources indexed (2011–2025), with 4 interaction records on file.
Core mechanism
Lurasidone antagonizes dopamine D2 and serotonin 5-HT2A receptors and has additional activity at 5-HT7, 5-HT1A, and alpha-2C receptors. Antipsychotic and mood effects are attributed to dopamine-serotonin modulation. It is primarily metabolized by CYP3A4, so strong CYP3A4 inhibitors or inducers can produce unsafe exposure changes and are contraindicated.1,2
Must be taken with food containing at least 350 calories; fasting administration markedly lowers exposure and can reduce efficacy.
St. John's Wort is a strong CYP3A4 inducer and can markedly lower lurasidone exposure.
Recommendation: Do not combine St. John's Wort with lurasidone.
Melatonin can add to lurasidone-related somnolence or dizziness.
Recommendation: Use cautiously and avoid hazardous activities if sedated.
L-Theanine may add calming or sedating effects to lurasidone.
Recommendation: Use cautiously, especially during dose changes or if already sleepy.
Ashwagandha can cause sedation in some patients and may add to lurasidone's CNS effects.
Recommendation: Use cautiously and avoid combining with other sedatives unless approved by the prescriber.
Numbered references. Citations throughout the page link here.
Review summarizes antipsychotic efficacy and common adverse effects including akathisia and somnolence.
Labeling documents 350-calorie administration requirement, dosing, CYP3A4 contraindications, and boxed warnings.
Food-effect data support the 350-calorie administration requirement in labeling.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.